Insurers retreat from MA. What’s the patient impact?

Many insurers seem to be retreating from Medicare Advantage by exiting unprofitable markets and reducing benefits. This could be extremely disruptive to patients, experts warn.

Editor's Pick

Top Story Insurers are Pulling Back on MA. How Does this Affect Patients? Many insurers seem to be retreating from Medicare Advantage by exiting unprofitable markets and reducing benefits. This could be extremely disruptive to patients, experts warn. Sponsored Reducing Payment Bottlenecks for Providers and Payers Presented by Zelis Yusuf Qasim, President of Payments Optimization at Zelis, discusses how the company is transforming healthcare payments from a fragmented, patchwork system into a modern, digital infrastructure. See the full interview Tell Us What You Want to See More Of Your voice helps shape the stories, insights, and events we deliver. Take just a few minutes to complete our short, anonymous audience survey and let us know what you enjoy and what you'd like to see more of. As a thank you, you'll be entered for a chance to win a $250 Amazon gift card. Take Survey Now

Featured News

First Therapy for Rare Tumor Is a Blockbuster Prospect, But Does Precigen Have the Cash to Make It Happen? Precigen's Papzimeos is the first FDA-approved drug for the rare disease recurrent respiratory papillomatosis, or RRP. While this immunotherapy carries blockbuster expectations, Precigen's financial reports indicate budgetary challenges. AI Meets Care Transitions: How One Startup Is Seeking to Reduce Readmissions and Costs Boston-based startup Cascala Health raised an $8.6 million seed round to expand its AI platform for risk-bearing providers. The platform is designed to make patient care transitions safer and more efficient, as well as to help care teams spot risks earlier. After Wegovy's Historic MASH Approval, What's Next? Approval is only the beginning. Now comes the harder part: identifying the right patients, detecting the disease earlier, and monitoring outcomes so that this promising treatment is effective at scale. Secretary Kennedy's Pride and Prejudice His longstanding anti-vaccine rhetoric and vocal opposition to science-backed expert consensus has caused widespread concern among public health and medical professionals about the appropriateness of his leadership.

Video   Should For-Profit Companies Be Administering Medicare Advantage Plans? The House Ways and Means Committee's joint oversight and health subcommittee hearing on Medicare Advantage focused on fraud, waste and abuse.  The hearing had seven witnesses, and two of them were the CEOs of Medicare Advantage plans Alignment Health and Scan Health. Notably absent were several large payers, like UnitedHealthcare and Humana, despite past investigations and fines.  This begs the question: should for-profit health plans even be in the business of selling Medicaid Advantage plans?

Sponsored The Definitive Guide to Medical Billing Outsourcing: 5 Top Companies Presented by Global Healthcare Resource In today's healthcare landscape, your choice of medical billing partner directly impacts your bottom line. What are the best medical billing outsourcing companies, and which one is right for you? Learn More.

Resources

MedCity Pivot Podcast: Clinical Documentation Improvement With Smarter Technologies Smarter Technologies CEO Jeremy Delinsky explains how the company's AI infrastructure can help support health system's clinical documentation improvement efforts, ultimately strengthening RCM. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe